Haleon Belgium
De berekende faillissementskans van Haleon Belgium over 12 maanden bedraagt 0,3% (zeer laag). Het bedrijf is actief sinds 1968 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 58 jaar |
| Bestuur | 4 |
| Vestigingen | 1 |
| Publicaties | 24 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | volledig | 21-08-2025 | 2025-00447507 |
| 31-12-2023 | volledig | 03-10-2024 | 2024-00504113 |
| 31-12-2022 | volledig | 04-07-2023 | 2023-00226763 |
| 31-12-2021 | volledig | 30-05-2022 | 2022-20050556 |
| 31-12-2020 | volledig | 15-06-2021 | 2021-20700151 |
| 31-12-2019 | volledig | 13-07-2020 | 2020-29500518 |
| 31-12-2018 | volledig | 04-09-2019 | 2019-63900101 |
| 31-12-2017 | volledig | 10-09-2018 | 2018-62600354 |
| 31-12-2016 | volledig | 30-11-2017 | 2017-70800462 |
| 31-12-2015 | volledig | 27-07-2016 | 2016-37800480 |
-
Marco DorigoBestuurderStaatsblad-akte 24003060 (05-01-2024)Actief05-01-2024 → heden
-
Sabena SolomonGedelegeerd bestuurderStaatsblad-akte 22061047 (19-05-2022)Actief19-05-2022 → heden
-
Gilles MartinBestuurderStaatsblad-akte 24003060 (05-01-2024)Actief01-10-2020 → heden
3 gebeurtenissen
- 05-01-2024 Benoemd· Bestuurder
- 19-05-2022 Benoemd· Bestuurder
- 01-10-2020 Benoemd· Bestuurder
-
Jorg Van DammeBestuurderStaatsblad-akte 24003060 (05-01-2024)Actief26-02-2019 → heden
3 gebeurtenissen
- 05-01-2024 Benoemd· Bestuurder
- 19-05-2022 Benoemd· Bestuurder
- 26-02-2019 Benoemd· Bestuurder
Historisch, niet recent bevestigd (3)
-
Sofi NAERTBestuurderStaatsblad-akte 16111564 (08-08-2016)Niet recent bevestigdlaatst bevestigd in akte van 2016
-
Anne DelzongleBestuurderStaatsblad-akte 07081013 (07-06-2007)Niet recent bevestigdlaatst bevestigd in akte van 2007
-
Andrew WatersBestuurderStaatsblad-akte 05110644 (01-08-2005)Niet recent bevestigdlaatst bevestigd in akte van 2005
Vaste vertegenwoordigers (1)
-
Ellemarie BexVaste vertegenwoordiger commissarisStaatsblad-akte 23164895 (22-12-2023)Vaste vertegenwoordiger22-12-2023 → heden
Voormalige bestuurders (15)
-
Dries PattynGedelegeerd bestuurderStaatsblad-akte 20114643 (01-10-2020)Voormalig01-10-2020 → 06-06-2023
3 gebeurtenissen
- 06-06-2023 Ontslagen· Gedelegeerd bestuurder en bestuurder
- 19-05-2022 Ontslagen· Gedelegeerd bestuurder
- 01-10-2020 Benoemd· Gedelegeerd bestuurder
-
Hans MoonsBestuurderStaatsblad-akte 19011556 (23-01-2019)Voormalig23-01-2019 → 01-10-2020
2 gebeurtenissen
- 01-10-2020 Ontslagen· Bestuurder
- 23-01-2019 Benoemd· Bestuurder
-
James BarhamBestuurderStaatsblad-akte 18186083 (31-12-2018)Voormalig31-12-2018 → 01-10-2020
3 gebeurtenissen
- 01-10-2020 Ontslagen· Gedelegeerd bestuurder
- 31-12-2018 Benoemd· Bestuurder
- 31-12-2018 Benoemd· Gedelegeerd bestuurder
-
Libor BALLEKBestuurderStaatsblad-akte 16111564 (08-08-2016)Voormalig25-07-2016 → 26-02-2019
3 gebeurtenissen
- 26-02-2019 Ontslagen· Bestuurder
- 08-08-2016 Benoemd· Bestuurder
- 25-07-2016 Benoemd· Bestuurder
-
Celesta BloemenBestuurderStaatsblad-akte 17160702 (16-11-2017)Voormalig16-11-2017 → 23-01-2019
2 gebeurtenissen
- 23-01-2019 Ontslagen· Bestuurder
- 16-11-2017 Benoemd· Bestuurder
| Commissaris / bedrijfsrevisor | IBR/IRE-nummer | Periode |
|---|---|---|
| KPMG Bedrijfsrevisoren BV/SRLActief Commissaris |
- | 22-12-2023 → heden |
Toon 8 eerdere commissarissen
| Deloitte Bedrijfsrevisoren BV Commissaris |
- | - → 22-12-2023 |
| Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL Commissaire opgevolgd door KPMG Bedrijfsrevisoren BV/SRL in 2023 |
- | 16-11-2021 → 22-12-2023 |
| Deloitte Réviseurs d'Entreprises SCRL Commissaire opgevolgd door Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL in 2021 |
- | 29-01-2019 → 16-11-2021 |
| Didier DELANOYE Commissaire opgevolgd door Deloitte Réviseurs d'Entreprises SCRL in 2019 |
- | 08-08-2016 → 29-01-2019 |
| Emmanuelle Attout Commissaire opgevolgd door SCCRL PwC Reviseurs d'Entreprises in 2016 |
- | 04-08-2010 → 08-08-2016 |
| PricewaterhouseCoopers Reviseurs d'Entreprises SCRL Commissaire opgevolgd door Emmanuelle Attout in 2010 |
- | 07-06-2007 → 04-08-2010 |
| PricewaterhouseCoopers Réviseurs d'Entreprises SCRL Commissaire |
- | - → 29-01-2019 |
| SCCRL PwC Reviseurs d'Entreprises Commissaire opgevolgd door Deloitte Réviseurs d'Entreprises SCRL in 2019 |
- | 08-08-2016 → 29-01-2019 |
| NACE primair | Groothandel in farmaceutische en medische artikelen(46460) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 01-01-1968 |
| Status | Actief |
| Postcode | 1930 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 23094D0081/00F003 | Vlaanderen | 8.103 m² | 1 · 1.497 m² | 38,6 m · 12 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
Wij kennen 33 Staatsblad-aktes van dit bedrijf. Daarvan is er nog geen enkele gelezen: wat erin staat, is hier niet vastgesteld en ook niet weerlegd.
05-01-2024 3 bestuurders benoemd
- Marco Dorigo, Bestuurder
- Gilles Martin, Bestuurder
- Jorg Van Damme, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marco Dorigo",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gilles Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jorg Van Damme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Haleon Belgium"
}
}22-12-2023 2 bestuurders benoemd, 1 ontslagnemend
- KPMG Bedrijfsrevisoren BV/SRL, Commissaris
- Ellemarie Bex, Vaste vertegenwoordiger commissaris
- Deloitte Bedrijfsrevisoren BV, Commissaris
Technische details
{
"events": [
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Deloitte Bedrijfsrevisoren BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "KPMG Bedrijfsrevisoren BV/SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Ellemarie Bex",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Haleon Belgium"
}
}06-06-2023 Dries Pattyn neemt ontslag als gedelegeerd bestuurder en bestuurder
- Dries Pattyn, Gedelegeerd bestuurder en bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd bestuurder en bestuurder",
"person": {
"rrn": null,
"name": "Dries Pattyn",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Haleon Belgium"
}
}02-03-2023 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Tim Carnewal",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-03-02",
"filing_date": null,
"act_kind_objet": "TRANSFERT DU SIEGE VERS LA REGION FLAMANDE"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-02-17",
"unanimous": null
},
"conversion": {
"effective_date": null,
"jurisdiction_to": "BE",
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"jurisdiction_from": "BE",
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0404.195.238",
"name": "GlaxoSmithKline Consumer Healthcare",
"role": "demerged",
"address": "1300 Wavre, Avenue Pascal 2-4-6",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:103"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "Le si\u00E8ge social de la soci\u00E9t\u00E9 est transf\u00E9r\u00E9 de Wavre \u00E0 Zaventem, en R\u00E9gion flamande. L\u0027activit\u00E9 de la soci\u00E9t\u00E9 est maintenue, mais la langue de fonction passera au n\u00E9erlandais.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim Carnewal",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de GlaxoSmithKline Consumer Healthcare a d\u00E9cid\u00E9 de transf\u00E9rer le si\u00E8ge social de Wavre \u00E0 Zaventem, en R\u00E9gion flamande. \u00C0 compter de ce transfert, la langue de la soci\u00E9t\u00E9 deviendra le n\u00E9erlandais.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "zetel"
}24-02-2023 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Haleon Belgium",
"old": "GlaxoSmithKline Consumer Healthcare",
"changed": true
},
"seat_change": {
"changed": true
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}24-02-2023 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Haleon Belgium",
"old": "GlaxoSmithKline Consumer Healthcare",
"changed": true
},
"seat_change": {
"changed": true
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}19-05-2022 3 bestuurders benoemd, 1 ontslagnemend
- Gilles Martin, Bestuurder
- Sabena Solomon, Gedelegeerd bestuurder
- Jorg Van Damme, Bestuurder
- Dries Pattyn, Gedelegeerd bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Gilles Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Dries Pattyn",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Sabena Solomon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jorg Van Damme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}16-11-2021 Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL benoemd tot commissaire
- Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL, Commissaire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Glaxosmithkline Consumer Healthcare"
}
}01-10-2020 2 bestuurders benoemd, 2 ontslagnemend
- Gilles Martin, Bestuurder
- Dries Pattyn, Gedelegeerd bestuurder
- Hans Moons, Bestuurder
- James Barham, Gedelegeerd bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hans Moons",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Gilles Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "James Barham",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Dries Pattyn",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}26-02-2019 1 bestuurder benoemd, 1 ontslagnemend
- Jorg Van Damme, Bestuurder
- Libor Ballek, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Libor Ballek",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jorg Van Damme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}29-01-2019 1 bestuurder benoemd, 1 ontslagnemend
- Deloitte Réviseurs d'Entreprises SCRL, Commissaire
- PricewaterhouseCoopers Réviseurs d'Entreprises SCRL, Commissaire
Technische details
{
"events": [
{
"kind": "director_out",
"role": "commissaire",
"person": {
"rrn": null,
"name": "PricewaterhouseCoopers R\u00E9viseurs d\u0027Entreprises SCRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises SCRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}23-01-2019 1 bestuurder benoemd, 1 ontslagnemend
- Hans Moons, Bestuurder
- Celesta Bloemen, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Celesta Bloemen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hans Moons",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}31-12-2018 2 bestuurders benoemd, 1 ontslagnemend
- James Barham, Bestuurder
- James Barham, Gedelegeerd bestuurder
- Olivier Bronkhorst, Gedelegeerd bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Olivier Bronkhorst",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "James Barham",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "James Barham",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}13-04-2018 2 bestuurders benoemd, 2 ontslagnemend
- Olivier Bronkhorst, Bestuurder
- Olivier Bronkhorst, Gedelegeerd bestuurder
- Bas Vorsteveld, Bestuurder
- Bas Vorsteveld, Gedelegeerd bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bas Vorsteveld",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bas Vorsteveld",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Olivier Bronkhorst",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Olivier Bronkhorst",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}16-11-2017 1 bestuurder benoemd, 1 ontslagnemend
- Celesta Bloemen, Bestuurder
- Sofie Naert, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Sofie Naert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Celesta Bloemen",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}12-06-2017 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}17-10-2016 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": "completed",
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2016-10-17",
"filing_date": "2016-07-11",
"act_kind_objet": "FUSION PAR ABSORPTION DE NOVARTIS CONSUMER HEALTH -"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2016-09-26",
"unanimous": null
},
"conversion": {
"effective_date": null,
"jurisdiction_to": "BE",
"legal_form_after": "soci\u00E9t\u00E9 anonyme",
"jurisdiction_from": "BE",
"legal_form_before": "soci\u00E9t\u00E9 anonyme"
},
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0404.195.238",
"name": "GlaxoSmithKline Consumer Healthcare",
"role": "acquiring",
"address": "Site Apollo, avenue Pascal 2-4-6, 1300 Wavre",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0403.097.356",
"name": "NOVARTIS CONSUMER HEALTH",
"role": "absorbed",
"address": "1800 Vilvoorde, Medialaan 40",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": 695.46,
"legal_articles": [
"12:7",
"12:50",
"12:75",
"12:103",
"693"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2015-12-31",
"exchange_ratio_text": "695,46 nouvelles actions au nom de la Soci\u00E9t\u00E9 Absorbante contre remise de 1 action de la Soci\u00E9t\u00E9 Absorb\u00E9e",
"new_shares_issued_n": 208637,
"real_estate_included": false,
"patrimony_description": "La totalit\u00E9 du patrimoine de la Soci\u00E9t\u00E9 Absorb\u00E9e, sans exception ni r\u00E9serve, est transf\u00E9r\u00E9e \u00E0 titre universel \u00E0 la Soci\u00E9t\u00E9 Absorbante. L\u0027op\u00E9ration inclut le transfert universel du patrimoine, y compris les actifs, passifs et droits.",
"equity_transferred_eur": null,
"accounting_effective_date": "2016-01-01"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare",
"legal_form": "soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Eubelius",
"person_name": null,
"org_rep_person_name": "Rebecca Danby, Ewout Epping, Jorg van Damme"
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de GlaxoSmithKline Consumer Healthcare, r\u00E9unie le 26 septembre 2016, a approuv\u00E9 la fusion par absorption de NOVARTIS CONSUMER HEALTH, dont le patrimoine a \u00E9t\u00E9 transf\u00E9r\u00E9 universellement \u00E0 la soci\u00E9t\u00E9 absorbante. Cette fusion a \u00E9t\u00E9 effectu\u00E9e conform\u00E9ment aux dispositions de l\u0027article 693 du Code des soci\u00E9t\u00E9s, avec attribution de 208.637 nouvelles actions \u00E0 l\u0027actionnaire unique de la soci\u00E9t\u00E9 absorb\u00E9e, au taux d\u0027\u00E9change de 695,46 nouvelles actions par action existante. Le capital social de GlaxoSmithKline Consumer Healthcare a \u00E9t\u00E9 augment\u00E9 \u00E0 5.798.470,50 EUR.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"une procuration",
"le texte coordonn\u00E9 des statuts"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}08-08-2016 4 bestuurders benoemd, 2 ontslagnemend
- Libor BALLEK, Bestuurder
- Sofi NAERT, Bestuurder
- SCCRL PwC Reviseurs d'Entreprises, Commissaire
- Didier DELANOYE, Commissaire
- Simon HODGE, Bestuurder
- Carlton LAWSON, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Simon HODGE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Carlton LAWSON",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Libor BALLEK",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Sofi NAERT",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "SCCRL PwC Reviseurs d\u0027Entreprises",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Didier DELANOYE",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}25-07-2016 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": "proposal",
"notary": {
"name": "Joris De Wolf",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2016-07-25",
"filing_date": "2016-06-23",
"act_kind_objet": ""
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2016-06-23",
"unanimous": true
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0404.195.238",
"name": "GlaxoSmithKline Consumer Healthcare SA",
"role": "acquiring",
"address": "Avenue Pascal 2-4-6, 1300 Wavre (Belgique)",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0403.097.356",
"name": "Novartis Consumer Health NV",
"role": "absorbed",
"address": "Medialaan 40, 1800 Vilvoorde (Belgique)",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": 695.46,
"legal_articles": [
"693",
"74",
"648"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2015-12-31",
"exchange_ratio_text": "695,46 Nouvelles Actions pour chaque action",
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "Tous les actifs et passifs de Novartis Consumer Health NV sont transf\u00E9r\u00E9s \u00E0 GlaxoSmithKline Consumer Healthcare SA par un transfert d\u0027universalit\u00E9. Le patrimoine transf\u00E9r\u00E9 inclut les activit\u00E9s pharmaceutiques, chimiques et alimentaires, ainsi que les brevets, marques et licences associ\u00E9s.",
"equity_transferred_eur": null,
"accounting_effective_date": "2016-01-01"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Joris De Wolf",
"org_rep_person_name": null
},
"summary_narrative": "Le projet de fusion par absorption pr\u00E9voit la dissolution sans liquidation de Novartis Consumer Health NV, dont tous les actifs et passifs seront transf\u00E9r\u00E9s \u00E0 GlaxoSmithKline Consumer Healthcare SA. En \u00E9change, les actionnaires de NVS Belgique recevront 695,46 nouvelles actions nominatives sans valeur nominale. La fusion prendra effet le 1er octobre 2016, avec une r\u00E9troactivit\u00E9 comptable et fiscale \u00E0 partir du 1er janvier 2016. Les assembl\u00E9es g\u00E9n\u00E9rales extraordinairement des actionnaires seront tenues vers le 23 septembre 2016.",
"co_filed_documents": [
"Rapport du commissaire de NVS Belgique",
"Rapport du commissaire de GSK Belgique",
"Comptes annuels des trois derniers exercices de GSK Belgique et NVS Belgique",
"Rapports du conseil d\u0027administration et du commissaire pour les trois derniers exercices"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}04-02-2016 Bas Vorsteveld benoemd tot bestuurder
- Bas Vorsteveld, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bas Vorsteveld",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}17-06-2015 3 bestuurders benoemd, 3 ontslagnemend
- Carlton LAWSON, Bestuurder
- Simon HODGE, Bestuurder
- Bas VORSTEVELD, Bestuurder
- Anton VAN DE PUTTE, Bestuurder
- Adrian BAUER, Bestuurder
- René FLASCHKER, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Anton VAN DE PUTTE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Adrian BAUER",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ren\u00E9 FLASCHKER",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Carlton LAWSON",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Simon HODGE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bas VORSTEVELD",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}04-08-2010 Emmanuelle Attout benoemd tot commissaire
- Emmanuelle Attout, Commissaire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Emmanuelle Attout",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}07-06-2007 2 bestuurders benoemd, 1 ontslagnemend
- Anne Delzongle, Bestuurder
- PricewaterhouseCoopers Reviseurs d'Entreprises SCRL, Commissaire
- Georges Dassonville, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Georges Dassonville",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Anne Delzongle",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SCRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}01-08-2005 1 bestuurder benoemd, 1 ontslagnemend
- Andrew Waters, Bestuurder
- Schipper, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Schipper",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Andrew Waters",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}| Officiële naamFR | Haleon Belgium |
| Officiële naamNL | Haleon Belgium |